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Table 2. Correlations between KL grading and natural antibodies
expression
BK-IgG 0.897 0.0005
DA-IgG 0.489 0.0027
HA-IgG 0.381 0.0045
PGE2-IgG 0.832 0.0001
Conclusions: Our working group has focused on the development of
immune markers which useful in the assessment of OA. Pathogenic NA
belongs mainly to the IgG isotype. IgG to inﬂammatory pain agents
would be potent diagnostic markers for OA and may play pathogenic
roles in the development of OA. Taken together (BK-IgG, DA-IgG, HA-IgG,
PGE2-IgG), our results cold promote the understanding of the role of
immunity in OA.
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PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR a ACTIVATION
COUNTERACTS INTERLEUKIN 1b INDUCED CYTOKINE PRODUCTION
BY INFRAPATELLAR FAT PAD
S. Clockaerts1,2, Y.M. Bastiaansen-Jenniskens2, C. Feijt2, J. An2, L. De
Clerck1, J. Somville1, G.J. van Osch2. 1Univ. of Antwerp, Edegem, Antwerp,
Belgium; 2Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: The infrapatellar fat pad (IPFP) is located in the knee joint,
closely to the cartilage and synovial layer. It contains adipocytes, nerve
ﬁbers, macrophages and other immune cells capable of producing
cytokines that can inﬂuence the osteoarthritis (OA) etiopathogenesis.
Peroxisome proliferator activated receptor a (PPARa) is a nuclear receptor
type I and member of the superfamily of ligand-dependent transcription
factors, regulating the transcription of target genes by binding retinoid
X receptor. PPARa agonists such as ﬁbrates are used in clinical practice
as lipid lowering drugs and are also known to exert anti-inﬂammatory
effects on various tissues.
We hypothesized that the IPFP is involved in the OA process by producing
cytokines and that the production can be altered by pro- and anti-
inﬂammatory stimuli.
Methods: IPFP explants of 29 OA patients were obtained during total
knee arthroplasty. The explants were cultured during 24 hours and the
supernatant was analyzed with Luminex. IPFP and synovium explants
of 5 OA patients were cultured during 48 hours with or without
IL1b and 100mM Wy-14643, a selective and potent PPARa ligand.
mRNA expression of IL1b, monocyte chemoattractant protein(MCP)1,
IL6, tumor necrosis factor(TNF)a, leptin, vascular endothelial growth
factor(VEGF), IL10, cyclo-oxygenase(COX)2 and release of TNFa, MCP1
and prostaglandin(PG)E2 were determined. We used linear mixed models
to analyze the results. To account for differences in IL1b response
between donors, we analyzed the interaction between the effect of
PPARa activation and the response to IL1b.
Results: IPFP released cytokines such as IFNg, IL4 or IL10, additional to
the ones previously described. The addition of IL1b to the IPFP explants
increased mRNA expression of cytokines, besides leptin and IL10. Analysis
of the supernatant conﬁrmed these results. Similar results were observed
for synovium, except for VEGF that was not increased by adding IL1b
(Figure 1).
Fig. 1. Averaged mRNA expression level relative to control value. White
bars represent controls and dark bars the IL1b induced explants.
*p < 0.05.
In IPFP explants, there was a signiﬁcant interaction between IL1b
response and the effect of PPARa for TNFa (p = 0.003), IL1b (p < 0.0001),
MCP1 (p =0.003), leptin (p < 0.0001), VEGF (p < 0.0001) and COX2
(p < 0.0001), indicating that the effect of PPARa activation was dependant
on the effect of IL1b. There was no interaction for IL6 (p = 0.92) and IL10
(p =0.45). These results were conﬁrmed when analyzing the supernatant.
PPARa did not decrease mRNA expression of cytokines in the synovium
explants.
Conclusions: IPFP is an important source of cytokines and their
production is increased by IL1b and decreases by a PPARa ligand.
Therefore, IPFP is an active OA joint tissue and target for potential
disease modifying drugs such as ﬁbrates.
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ANALYSIS OF ANTI-INFLAMMATORY EFFECTS OF LANSOPRAZOLE
ON MACROPHAGES
H. Inoue1, Y. Arai1, S. Nakagawa1, R. Terauchi1, N. Hiraoka1, S. Tsuchida1,
R. Sakai1, O. Mazda2, T. Kubo1. 1Dept. of Orthopaedics, Graduate Sch. of
Med. Sci., Kyoto, Japan; 2Dept. of Immunology, Graduate Sch. of Med. Sci.,
Kyoto, Japan
Purpose: Lansoprazole (LPZ) is a typical proton pump inhibitor used
in clinical practice for treatment of gastrointesutinal mucosal disorders
caused by gastric acid hypersecretion, such as gastric ulcer and reﬂux
esophagitis. Meanwhile, LPZ inhibits macrophage adhesion molecule
expression. However, for activated macrophages in which dysfunction
occurs, overproduction of inﬂammatory mediators such as nitric oxide
(NO) and prostaglandin E2 (PGE2) is involved in the pathogenesis
of many inﬂammatory diseases, including rheumatoid arthritis. The
purpose of this study is to analyze the anti-inﬂammatory effects of
LPZ on macrophages.
Methods: RAW264.7 murine macrophages were obtained from the
Riken Cell Bank (Ibaragi, Japan). The effect of LPZ on cell viability
was tested using MTT assay after addition of LPZ at concentrations
of 0, 20, 50, 100, 200, 400mM. The amount of nitrite and PGE2 was
indicated by the amount that was measured in the RAW264.7 cell
culture supernatant. RAW264.7 cells were cultured and were treated
with several concentrations of LPZ. LPS was added to the culture medium.
To evaluate whether the inhibitory effects of LPZ on LPS-induced NO and
PGE2 production were mediated by iNOS and COX-2 protein expression,
we performed Western blot analysis.
Results: When we examined the effects of LPZ on RAW cell viability,
at concentrations of 0–100mM, no effects were seen. LPZ inhibited LPS-
induced production of nitrite in a concentration-dependent manner. In
particular, LPZ at a concentration of 100mM inhibited nitrite production
to the same extent as the control. With LPS stimulation, PGE2 levels
in the culture supernatant increased, but with LPZ pretreatment at
concentrations of 50 and 100mM, PGE2 levels also decreased. Expression
of iNOS and COX-2 was also inhibited by LPZ at a concentration of
100mM.
Conclusions: Our study showed not only inhibition of NO and PGE2
production in RAW 264.7 cells stimulated with LPS, but also suppression
of iNOS and COX-2 expression. iNOS is involved closely with regulation of
the inﬂammatory response via producing NO. The rate-limiting enzyme
in PGE2 synthesis is COX-2. Based on our study results, LPZ exerts anti-
inﬂammatory effects by suppressing iNOS and COX-2 expression. LPZ
may be promising for use in many inﬂammatory diseases in which
activated macrophages play a role, such as rheumatoid arthritis.
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VITAMIN D EFFECT ON MOLECULES ASSOCIATED TO OSTEOARTHRITIS
PROGRESSION INDUCED IN RATS
E.C. Castillo1, R.M. del Angel1, M. Vega-Lo´pez1, F. Navarro-Garcı´a2,
C. Lavalle3, V. Ortiz-Navarrete4, J.B. Kouri1. 1CINVESTAV-IPN. Infecto´mica
y Patoge´nesis Molecular, Me´xico, D. F., Mexico; 2CINVESTAV-IPN. Biolog´ıa
Celular, Me´xico, D. F., Mexico; 3UNAM. Facultad de Med., Me´xico, D. F.,
Mexico; 4CINVESTAV-IPN. Biomedicina Molecular, Me´xico, D. F., Mexico
Purpose: The aim of this study was to evaluate the effect of the vitamin
D on the TLRs, cytokines and metolloproteases expression in a rat model
of osteoarthritis (OA).
Methods: Unilateral knee menisectomy plus 1, 3, 6, 8, 10 and 20 days of
high impact exercise was performed in order to induce OA. Normal rats
were used as a control. Rats were sacriﬁced by CO2 overdose, cartilage
explants were used for immunohistoﬂuorence assay and enzymatically
isolated chondrocytes from the right femoral condyles were used for qRT-
PCR analysis. The mRNA relative levels for TLRs (TLR-1, TLR-2, TLR-4,
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TLR-6), cytokines (IL-1b, IL-6, TNF-a) and metalloproteases (MMP-13,
MMP-3 and MMP-9) were determinate in normal, OA rats and OA rats
treated with 100ng/d of 1,25(OH)2D3 (4IU).
Results: TLR-1, TLR-2 and TLR-6 were detected along the progression
of OA but their expression did not differ signiﬁcantly with the control
group. Remarkable, a signiﬁcant increased (p < 0.05; p < 0.0001) of TLR4
mRNA expression was observed since day 8 (2.5 fold) of OA induction.
By immunohistoﬂuorescence, TLR-4 was detected in the superﬁcial and
middle zones of cartilage from day 3 to 20 with highest expression at
day 8. In another hand, a notably level of IL-1b expression (19 fold) was
observed at day 8 of OA induction (p < 0.0001), while TNFa and IL-6
did not show a signiﬁcant difference within the experimental groups.
Among the MMPs, the MMP-3 showed the highest expression at the
8 (2.8 fold; p < 0.05) and 10 (3 fold; p < 0.0001) days of OA. Vitamin D
treatment showed a clear reduction of TLR4, IL-1b and MMP-3 during
the progression (3, 10 and 20 days) of OA.
Conclusions: TLR4 is expressed in rat articular cartilage and it is up
regulated during the induction of OA. Signaling through TLR-4 might
be the pro-inﬂammatory mechanism in osteoarthritis that results in the
expression of IL-1b and MMP-3. Interfering this signaling pathway by
the use of vitamin D reduce the progression of OA in the rat model.
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INHIBITION OF PRO-INFLAMMATORY MEDIATORS IN ACTIVATED
HUMAN ARTICULAR CARTILAGE BY THE COMBINATION OF
AVOCADO/SOYBEAN UNSAPONIFIABLES, GLUCOSAMINE, AND
CHONDROITIN SULFATE AND BY ASPIRIN
L.F. Heinecke1, M.W. Grzanna1, A.Y. Au1,2, C.G. Frondoza1,3. 1Nutramax
Lab., Inc., Edgewood, MD, USA; 2Syracuse Univ., Syracuse, NY, USA; 3Johns
Hopkins Univ., Baltimore, MD, USA
Purpose: We evaluated the anti-inﬂammatory effect of the combination
of avocado/soybean unsaponiﬁables (ASU), glucosamine (GLU), and
chondroitin sulfate (CS) by measuring production of pro-inﬂammatory
mediators by human articular cartilage. These mediators include
prostaglandin E2 (PGE2), interleukin-6 (IL-6), interleukin-8 (IL-8),
and macrophage chemotactic protein-1 (MCP-1). They are produced
excessively in osteoarthritis (OA) and play critical roles in the
pathogenesis of the disease. These pro-inﬂammatory mediators
participate in the destruction of articular cartilage by inducing enzymes
that degrade extracellular matrix. PGE2 activates cartilage-degrading
enzymes while IL-6 mediates bone resorption. These molecules also
activate inﬂammatory pain pathways. However, at physiologic levels,
these molecules serve multiple functions in cell signaling, proliferation,
tissue repair, and regeneration. Studies have demonstrated that ASU,
GLU, and CS inhibit production of inﬂammatory mediators. They have
been shown to reduce inﬂammation and relieve pain in OA patients
with no adverse effects. These compounds have also been reported as
chondroprotective and exert structure-modifying effects on osteoarthritic
knees. As positive control in our in vitro study, we used aspirin at a
clinically relevant concentration. Aspirin is a widely used non-steroidal
anti-inﬂammatory drug (NSAID) that has recently been cited as causing
gastro-intestinal side effects.
Methods: Human articular cartilage (Articular Engineering Inc.) was cut
into 200mg/well for explant experiments. Explants were pre-incubated
with: (a) control media alone, (b) the combination of ASU (NMX1000®,
8.3mg/ml) + GLU (FCHG49®, 11mg/ml) + CS (TRH122®, 20mg/ml); or (c)
aspirin (100mg/ml) for 24 hrs to seven days. Explants and chondrocytes
were then activated with IL-1b (5 or 10ng/ml) for 24–48 hrs for
measurement of PGE2, IL-6, IL-8, and MCP-1 production by ELISA.
Concentrations of mediators were expressed per mg cartilage wet weight
in explant culture. Data was analyzed by one-way ANOVA, Tukey post-
hoc, with P < 0.05 level of signiﬁcance.
Results: Cartilage explants from normal and OA donors cultured with
control media alone produced undetectable to low levels of PGE2, IL-6,
IL-8, andMCP-1. Activation with IL-1b (5 and 10ng/ml) resulted in similar,
signiﬁcantly increased production of pro-inﬂammatory mediators. These
increases were as much as 80-fold for PGE2, 500-fold for IL-6, 300-
fold for IL-8, and 700-fold for MCP-1 (all P < 0.001). The combination
of ASU+GLU+CS reduced PGE2production down to 10% of IL-1b-activated
levels. The effect of the ASU+GLU+CS combination on the cytokine-
induced production of other mediators was variable. Inhibition was
reduced to 10% of activated levels for IL-6, 40% for IL-8, and 15% for
MCP-1. In contrast, aspirin dramatically reduced production of PGE2
down to 1% of activated levels. Aspirin also decreased IL-6 production
down 10% of activated levels, 38% for IL-8, and 34% for MCP-1.
Conclusion: The present study shows that the combination of
ASU+GLU+CS effectively inhibits cytokine-induced production of PGE2,
IL-6, IL-8, and MCP-1 by cartilage explants. In comparison, aspirin nearly
obliterated the production of PGE2 and reduced the production of IL-6,
IL-8, and MCP-1. This suggests that the combination of ASU+GLU+CS
may have similar mechanisms of action as some NSAIDs such as aspirin.
However, the observation that ASU+GLU+CS attenuated rather than
dramatically suppressed production of PGE2 may help preserve their
physiologic functions. The present study supports the notion that the
ASU+GLU+CS combination may offer an effective anti-inﬂammatory and
chondroprotective approach for the management of OA. The ASU+GLU+CS
combination may help reduce chronic dosing of NSAIDS, thus minimizing
deleterious side effects.
431
INHIBITION OF CYTOKINE-INDUCED INFLAMMATORY GENE
EXPRESSION IN CHONDROCYTES FROM HORSES AFFLICTED WITH
HEREDITARY EQUINE REGIONAL DERMAL ASTHENIA (HERDA)
BY THE COMBINATION OF AVOCADO/SOYBEAN UNSAPONIFIABLES,
GLUCOSAMINE, AND CHONDROITIN SULFATE
S.L. Ownby1, L.C. Gardner2, D.B. Howard1, L.F. Heinecke1, M.W. Grzanna1,
A.Y. Au1,3, A.M. Rashmir-Raven4, C.G. Frondoza1,5. 1Nutramax Lab., Inc.,
Edgewood, MD, USA; 2Virginia-Maryland Regional Coll. of Vet. Med.,
Blacksburg, VA, USA; 3Syracuse Univ., Syracuse, NY, USA; 4Michigan State
Univ., East Lansing, MI, USA; 5Johns Hopkins Univ., Baltimore, MD, USA
Purpose: Hereditary Equine Regional Dermal Asthenia (HERDA) is an
autosomal recessive connective tissue disorder resulting in impaired
collagen folding, hyperextensible skin, and abnormal wound repair. We
observed osteoarthritic lesions in tarsal and carpal joints of yearling
HERDA horses. HERDA horses show similarities to the human hereditary
connective tissue syndrome Ehlers-Danlos (EDS). Many EDS patients
suffer from joint pain and osteoarthritis (OA) as adults. The phenotypic
similarities between EDS and HERDA suggest that horses suffering from
HERDA may also develop OA. In OA, excess production of inﬂammatory
mediators activates enzymes that degrade cartilage as well as inhibit
wound healing. These mediators include prostaglandin E2 (PGE2) whose
production is regulated by the cyclooxygenase-2 (COX-2) enzyme, tumor
necrosis factor-a (TNF-a), interleukin-6 (IL-6), and interleukin-8 (IL-8),
The purpose of this study was to characterize articular cartilage from
HERDA afﬂicted horses. We determined the baseline expression of several
pro-inﬂammatory genes and whether their expression could be induced
by the cytokine IL-1b similar to what is observed in OA joints. We
also determined whether induction of these genes could be inhibited by
the combination of avocado/soybean unsaponiﬁables (ASU), glucosamine
(GLU), and chondroitin sulfate (CS). ASU, GLU, and CS are known to inhibit
inﬂammation and are used for the management of OA in both humans
and animals. As a positive control, we used phenylbutazone (PBZ), a
non-steroidal anti-inﬂammatory drug (NSAID) currently used for the
management of both HERDA and equine OA.
Methods: Articular cartilage was harvested from tarsal joints of three
yearling HERDA horses. Chondrocytes were seeded onto 6-well plates
and pre-incubated at 37°C, 5% CO2with: control media alone, PBZ
at a clinically relevant concentration (4mg/mL), or the combination
of ASU (NMX1000®, 8.3mg/mL) + GLU (FCHG49®, 11mg/mL) + CS
(TRH122®, 20mg/mL) for 24 hours. Chondrocytes were activated with
IL-1b (10ng/mL) for 24 hrs. COX-2, IL-6, TNF-a, and IL-8 gene expression
was quantiﬁed by real-time PCR. Pair-wise multiple comparisons were
carried out using one-way ANOVA, Student-Newman-Keuls post-hoc
analysis where differences of P < 0.05 were considered statistically
signiﬁcant.
Results: Chondrocytes incubated with control media alone expressed
low levels of COX-2, IL-6, TNF-a, and IL-8. Cytokine activation induced
a hundred-fold increase (P < 0.001) in the expression of these pro-
inﬂammatory genes. Pre-treatment with ASU+GLU+CS signiﬁcantly
(P < 0.05) decreased COX-2, IL-6, TNF-a, and IL-8 expression by
approximately 30%. In comparison, cytokine-induced increases in COX-2,
IL-6, TNF-a, and IL-8 pro-inﬂammatory gene expression were inhibited
by PBZ by as much as 60% (P < 0.05).
Conclusions: Chondrocytes obtained from horses with HERDA responded
to cytokine stimulation with the up-regulation of several key pro-
inﬂammatory markers that have been associated with the pathogenesis
